HarrowHealth_LOGO_SHAPE_COLOR_WHITE_HOR-02.jpg
Harrow Health Publishes Third Quarter 2020 Letter to Stockholders
November 09, 2020 16:01 ET | Harrow Health, Inc.
NASHVILLE, Tenn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the third quarter 2020. Please click here to review Harrow Health’s Letter to...
HarrowHealth_LOGO_SHAPE_COLOR_WHITE_HOR-02.jpg
Harrow Health Appoints Larry Van Horn to its Board of Directors
September 30, 2020 08:00 ET | Harrow Health, Inc.
NASHVILLE, Tenn., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced the appointment of Larry Van Horn to its Board of Directors. Mark L. Baum, CEO of Harrow...
HarrowHealth_LOGO_SHAPE_COLOR_WHITE_HOR-02.jpg
Harrow Health to Attend Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020
September 11, 2020 11:22 ET | Harrow Health, Inc.
NASHVILLE, Tenn., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it will be attending Lake Street’s 4th Annual Best Ideas Growth (BIG4) Conference...
HarrowHealth_LOGO_SHAPE_COLOR_WHITE_HOR-02.jpg
Harrow Health Publishes Second Quarter 2020 Letter to Stockholders
August 10, 2020 16:00 ET | Harrow Health, Inc.
NASHVILLE, Tenn., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the second quarter 2020.  Please click here to review Harrow Health’s Letter to...
HarrowHealth_LOGO_SHAPE_COLOR_WHITE_HOR-02.jpg
Harrow Health to Announce Second Quarter 2020 Financial Results on August 10, 2020
July 27, 2020 07:30 ET | Harrow Health, Inc.
NASHVILLE, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of trading on Monday, August 10, 2020, it will release second quarter 2020...
HarrowHealth_LOGO_SHAPE_COLOR_WHITE_HOR-02.jpg
Leading Peer-Reviewed Journal Publishes Clinical Study on ImprimisRx’s Combination Prescription Eyedrops
July 13, 2020 07:30 ET | Harrow Health, Inc.
SAN DIEGO, July 13, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow...
HarrowHealth_LOGO_SHAPE_COLOR_WHITE_HOR-02.jpg
Harrow Health Set to Join Russell 2000® Index and Russell 3000® Index
June 29, 2020 07:30 ET | Harrow Health, Inc.
NASHVILLE, Tenn., June 29, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it is set to join the small-cap Russell 2000® Index and the broad-market Russell 3000®...
HarrowHealth_LOGO_SHAPE_COLOR_WHITE_HOR-02.jpg
ImprimisRx’s Patented Klarity-C® 0.1% Cyclosporine Preservative-Free Formulation May Now Be Prescribed By Florida’s 2,000 Optometrists
June 18, 2020 07:30 ET | Harrow Health, Inc.
SAN DIEGO, June 18, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow...
HarrowHealth_LOGO_SHAPE_COLOR_WHITE_HOR-02.jpg
Harrow Health Publishes First Quarter 2020 Letter to Stockholders
May 11, 2020 16:01 ET | Harrow Health, Inc.
NASHVILLE, Tenn., May 11, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the first quarter 2020.  Please click here to review Harrow Health’s Letter to...
HarrowHealth_LOGO_SHAPE_COLOR_WHITE_HOR-02.jpg
Harrow Health to Announce First Quarter 2020 Financial Results on May 11, 2020
April 27, 2020 07:30 ET | Harrow Health, Inc.
NASHVILLE, Tenn., April 27, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of trading on Monday, May 11, 2020, it will release first quarter 2020...